Ronald Kershner Appointed to Lead AAIPharma’s N. American Biostatistics and Data Management Services

Ronald Kershner joins AAIPharma to lead the Company’s North American Biostatistics and Data Management Services groups. Ronald brings over 25 years of industry experience at various large pharmaceutical, biotechnology and Contract Research companies. In previous roles with inVentiv, Inveresk and Omnicare, Ronald was responsible for the oversight of biostatistics and data management across a variety of therapeutic areas. Ronald brings significant experience with regulatory submissions and FDA interactions and has been involved in over 20 NDA submissions. Ronald also brings experience, focus and vision for implementation of EDC and eClinical technologies.

Ron will be responsible for functional and financial oversight of all biostatistics and data management activities for AAI in North America. In this role, Ron will work closely with clients to insure on-time, on-budget quality deliverables. In addition, Ron will be involved in new global technology initiatives that will ensure AAI will always be able to bring clients the best and most effective technological solutions implementing and managing clinical trials

About AAIPharma

AAIPharma Inc. is an international pharmaceutical services provider of product development and support services to the pharmaceutical, biotechnology, and medical device industries. AAIPharma’s service offerings include: analytical services, product development services, drug delivery technologies, contract manufacturing (solids and parenterals), clinical services (Phase I-IV), clinical packaging and distribution and bioanalytical services.

For more information on the Company, please visit AAIPharma's website at www.aaipharma.com.

Contact: Barry Johnson: Barry.Johnson@aaipharma.com